Details for 2016711931
Up to date per 04.04.2026
Actions
Details for 2016711931
Granted/Registered
European Patent
10.01.2018 A
22.07.2020 B1
04.03.2015
US
201562128472 P
25.09.2015
US
201562232644 P
A61K 31/4439 20060101AFI20160915BHEP
Owner
Vanda Pharmaceuticals Inc.2200 Pennsylvania Avenue NW Suite 300 Washington, DC 20037US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
POLYMEROPOULOS, Mihael, H.10627 Rivers Bend Lane Potomac, MD 20854US
LICAMELE, Louis, William2270 Dunster Lane Potomac, MD 20854US
Information about Fees